Modeling Complex Pharmacokinetics of Long‐Acting Injectable Products Using Convolution‐Based Models With Nonparametric Input Functions-Reference-Cited by-同舟云学术

Modeling Complex Pharmacokinetics of Long‐Acting Injectable Products Using Convolution‐Based Models With Nonparametric Input Functions

Published:2021-03-15 Issue: Volume: Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Gomeni Roberto¹,Bressolle‐Gomeni Françoise¹

Affiliation:

1. R&D Department, Pharmacometrica Longcol La Fouillade France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1842

Reference38 articles.

1. Strengths, weaknesses, opportunities and challenges for long‐acting injectable therapies: Insights for applications in HIV therapy;Owen A;Adv Drug Deliv Rev,2016

2. Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory

3. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics

4. Development and evaluation of intramuscularly administered nano/microcrystal suspension;Ma Z;Expert Opin Drug Deliv,2019

5. Sustained release injectable drug delivery. A review on the current status of long‐acting injectables, including commercially marketed products;Rhee Y‐S;Pharm Technol,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically-Based Pharmacokinetic Modeling and In Vitro–In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human;Pharmaceutics;2024-07-04

2. Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development;The AAPS Journal;2023-10-17

3. Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK models;CPT: Pharmacometrics & Systems Pharmacology;2023-10-16

4. Revisiting the in-vitro and in-vivo considerations for in-silico modelling of complex injectable drug products;Journal of Controlled Release;2023-08

5. Determining bioequivalence possibilities of long acting injectables through population PK modelling;European Journal of Pharmaceutical Sciences;2022-12